Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.20 USD
Change Today 0.0001 / 0.05%
Volume 58.5K
As of 8:10 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

nutra pharma corp (NPHC) Snapshot

Open
$0.20
Previous Close
$0.20
Day High
$0.23
Day Low
$0.19
52 Week High
08/6/14 - $0.43
52 Week Low
05/19/15 - $0.05
Market Cap
7.9M
Average Volume 10 Days
115.1K
EPS TTM
$-0.43
Shares Outstanding
39.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NUTRA PHARMA CORP (NPHC)

Related News

No related news articles were found.

nutra pharma corp (NPHC) Related Businessweek News

No Related Businessweek News Found

nutra pharma corp (NPHC) Details

Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, as well as homeopathic and ethical drugs for managing pain, neurological disorders, cancer, autoimmune, and infectious diseases. It offers Nyloxin/Nyloxin Extra Strength that are homeopathic drugs to treat moderate to severe chronic pain; and Pet Pain-Away, a homeopathic, non-narcotic, non-addictive, over-the-counter pain reliever primarily targeted at treating moderate to severe chronic pain in companion animals. The company is also developing RPI-78M to treat neurological diseases and autoimmune diseases, including multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, rheumatoid arthritis, and myasthenia gravis; RPI-MN to treat viral diseases, such as HIV/AIDS and Herpes; RPI-78 for pain and arthritis; RPI-70 for pain; and Equine Nyloxin, a topical therapy for horses, as well as Nyloxin Military Strength for sale to the United States Military and Veteran's Administration. Nutra Pharma Corp. was founded in 2000 and is headquartered in Coral Springs, Florida.

5 Employees
Last Reported Date: 04/13/15
Founded in 2000

nutra pharma corp (NPHC) Top Compensated Officers

Chairman, Chief Executive Officer, President,...
Total Annual Compensation: $130.0K
Compensation as of Fiscal Year 2014.

nutra pharma corp (NPHC) Key Developments

Nutra Pharma Corporation Enters into Facility and Personnel Sharing Agreement with Nationwide Laboratory Services, Inc

Nutra Pharma Corporation announced that they have entered into a facility and personnel sharing agreement with Nationwide Laboratory Services, Inc.

Nutra Pharma Corporation announced delayed 10-Q filing

On 05/18/2015, Nutra Pharma Corporation announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Nutra Pharma Corporation will Change its Ticker to NPHC.D from NPHC

Effective May 18, 2015, Nutra Pharma Corporation will change its Pink Sheets LLC stock ticker symbol to NPHC.D from NPHC.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NPHC:US $0.20 USD 0.0001

NPHC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bayer AG €126.19 EUR -0.71
Biogen Inc $404.28 USD -1.13
Roche Holding AG SFr.265.10 CHF -1.30
View Industry Companies
 

Industry Analysis

NPHC

Industry Average

Valuation NPHC Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 10.4x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 8.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NUTRA PHARMA CORP, please visit www.nutrapharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.